A Prospective Study of Electronic Symptom Reporting Via Mobile Phone Among Patients With Advanced Non-Small Cell Lung Cancer



Status:Recruiting
Conditions:Lung Cancer, Lung Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:9/22/2018
Start Date:May 21, 2018
End Date:November 21, 2019
Contact:Lawrence Shulman, MD
Email:PennCancerTrials@emergingmed.com
Phone:855-216-0098

Use our guide to learn which trials are right for you!

Symptoms are common among patients with advanced malignancy undergoing treatment, and yet
often go unrecognized by treatment providers. In addition to contributing to morbidity,
poorly controlled symptoms drive emergency room utilization and hospital admission in this
population, representing significant cost to patients, families, and the health care system.
Systematic collection of patient-reported outcomes (PROs) has been proposed as a way to arm
providers with the information necessary to intervene early, intensify symptom management,
and improve symptom control. Recent research suggests that a standardized, web-based program
of weekly patient-reported symptom monitoring leads to improved health-related quality of
life and reduced acute care utilization; it may also prolong overall survival. Despite
mounting evidence supporting its use among oncology patients, systematic PRO collection is
lacking at most cancer centers, and optimal models for collection of PROs are poorly
understood. The objective of this study is to evaluate prospectively the feasibility of a
novel mobile phone-based intervention of weekly symptom reporting, among patients undergoing
treatment for advanced non-small cell lung cancer.


Inclusion Criteria:

- Adult patient (age ≥ 18 years) with advanced (metastatic) non-small cell lung cancer,
initiating a new line of palliative-intent treatment at Abramson Cancer Center

- Ability to read and respond to questions in English

- Ability to provide informed consent to participate in the study

- Access to a smart phone capable of SMS-text messaging and internet access

Exclusion Criteria:

- Inability to read and respond to questions in English

- Inability or unwillingness to provide informed consent to participate in the study

- Inability to engage with SMS-text based platform

- Current enrollment in a clinical trial
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
(215) 662-6065
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials